Imitrex: Targeted Relief for Acute Migraine Attacks
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.79 | $143.62 (0%) | 🛒 Add to cart |
| 60 | $4.43 | $287.24 $265.74 (7%) | 🛒 Add to cart |
| 90 | $4.31 | $430.86 $387.86 (10%) | 🛒 Add to cart |
| 120 | $4.24
Best per pill | $574.48 $509.12 (11%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.21 | $126.42 $126.42 (0%) | 🛒 Add to cart |
| 60 | $3.78 | $252.84 $227.04 (10%) | 🛒 Add to cart |
| 90 | $3.64 | $379.26 $327.66 (14%) | 🛒 Add to cart |
| 120 | $3.56
Best per pill | $505.68 $427.42 (15%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $5.25 | $157.38 (0%) | 🛒 Add to cart |
| 60 | $4.69 | $314.76 $281.22 (11%) | 🛒 Add to cart |
| 90 | $4.51 | $472.14 $405.92 (14%) | 🛒 Add to cart |
| 120 | $4.42
Best per pill | $629.52 $530.62 (16%) | 🛒 Add to cart |
Synonyms
| |||
Imitrex (sumatriptan) is a prescription medication specifically formulated for the acute treatment of migraine headaches with or without aura in adults. It belongs to a class of drugs known as selective serotonin receptor agonists (triptans), which work by constricting blood vessels around the brain and blocking pain pathways in the cranial nerves. This targeted mechanism of action helps to alleviate the debilitating pain, nausea, and sensitivity to light and sound associated with migraines, allowing for a return to normal function. It is not intended for the prevention of migraines or for the treatment of cluster headaches or hemiplegic migraines.
Features
- Active Pharmaceutical Ingredient: Sumatriptan (as the succinate salt).
- Available Formulations: Tablets (25 mg, 50 mg, 100 mg), Nasal Spray (5 mg, 20 mg), and Subcutaneous Injection (4 mg, 6 mg autoinjectors and vials).
- Rapid Absorption: Subcutaneous injection provides the fastest onset of action, with relief often felt within 10 minutes.
- Selective Mechanism: Binds with high affinity to 5-HT1B and 5-HT1D receptors.
- Brand and Generic Availability: Available as the brand-name product Imitrex and in generic formulations.
Benefits
- Provides rapid and effective relief from the intense, throbbing pain of a migraine attack.
- Effectively reduces or eliminates associated migraine symptoms, including nausea, vomiting, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).
- Offers multiple administration routes (oral, nasal, injectable) to suit individual patient needs and preferences, especially for those experiencing severe nausea.
- The targeted action helps restore normal function, allowing patients to resume daily activities more quickly.
- Consistent efficacy in treating acute migraine episodes when taken at the onset of symptoms.
Common use
Imitrex is used for the acute treatment of migraine attacks. It is most effective when taken as soon as the symptoms of a migraine begin. It is not to be used to prevent migraines. Patients should not use this medication if they have certain types of underlying cardiovascular conditions. A diagnosis of migraine with or without aura should be confirmed by a healthcare provider before initiating treatment.
Dosage and direction
Dosage is individualized based on the formulation, severity of attacks, and patient response. The goal is to use the lowest effective dose.
- Tablets: The recommended initial dose is 25 mg, 50 mg, or 100 mg. If symptoms persist or return after initial relief, a second dose may be taken after at least 2 hours, not to exceed 200 mg in 24 hours.
- Nasal Spray: A single 5 mg or 20 mg spray in one nostril. If symptoms persist or return, a second dose may be taken after at least 2 hours, not to exceed 40 mg in 24 hours.
- Subcutaneous Injection: A single 4 mg or 6 mg injection. If symptoms persist or return, a second injection may be administered after at least 1 hour, not to exceed 12 mg in 24 hours.
The injection is for subcutaneous use only; intramuscular or intravenous administration is contraindicated. Patients should be instructed on the proper use of the autoinjector or nasal spray device.
Precautions
- Cardiovascular Evaluation: A cardiovascular evaluation is recommended for patients with risk factors for coronary artery disease (e.g., hypertension, high cholesterol, diabetes, smoking, obesity, strong family history) prior to initiating, and periodically during, treatment with Imitrex.
- Chest/Throat/Jaw Pain: Patients may experience pain, tightness, pressure, or heaviness in the chest, throat, neck, or jaw. While often non-cardiac, these symptoms require immediate medical evaluation to rule out serious cardiac events.
- Cerebrovascular Events: Imitrex is associated with a risk of stroke and other cerebrovascular events. Use is contraindicated in patients with a history of stroke or transient ischemic attack (TIA).
- Serotonin Syndrome: There is a potential risk of serotonin syndrome, particularly with concomitant use of other serotonergic drugs (e.g., SSRIs, SNRIs).
- Medication Overuse Headache: Overuse of acute migraine treatments (e.g., use on 10 or more days per month) may lead to medication-overuse headache. The patient’s headache pattern should be monitored.
- Seizures: Use with caution in patients with a history of epilepsy or conditions associated with a lowered seizure threshold.
Contraindications
Imitrex is contraindicated in patients with:
- Ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, documented silent ischemia).
- Coronary artery vasospasm, including Prinzmetal’s angina.
- History of stroke or transient ischemic attack (TIA).
- History of hemiplegic or basilar migraine.
- Peripheral vascular disease.
- Ischemic bowel disease.
- Uncontrolled hypertension.
- Hypersensitivity (allergy) to sumatriptan or any component of the formulation.
- Concurrent administration or within 2 weeks of discontinuing MAO-A inhibitors.
- Concurrent administration of other 5-HT1 agonists (e.g., other triptans) or ergotamine-containing medications.
Possible side effect
Not all patients will experience side effects. The most common are often formulation-specific and transient.
- Very Common (≥1/10): Sensations of tingling, warmth, heat, flushing, pressure, tightness, or heaviness in any part of the body (including the chest and throat); dizziness; drowsiness; feeling weak.
- Common (≥1/100 to <1/10): Nausea and vomiting; fatigue; transient increases in blood pressure.
- Injection-specific: Pain, redness, or burning at the injection site.
- Nasal Spray-specific: Unpleasant taste, nasal irritation/discomfort.
- Uncommon (≥1/1,000 to <1/100): Temporary visual disturbances, arrhythmias, palpitations, neck pain/stiffness.
- Rare but Serious: Coronary artery vasospasm, myocardial infarction, stroke, gastrointestinal ischemic events, serotonin syndrome, seizures, hypersensitivity reactions (including anaphylaxis).
Drug interaction
Concomitant use of Imitrex with the following medications requires careful consideration and monitoring due to increased risk of adverse effects:
- Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Increased risk of serotonin syndrome (e.g., citalopram, escitalopram, fluoxetine, paroxetine, sertraline, venlafaxine, duloxetine).
- Monoamine Oxidase-A Inhibitors (MAO-A Inhibitors): Contraindicated. Concomitant use significantly increases sumatriptan plasma levels and the risk of adverse reactions.
- Ergotamine Derivatives (e.g., ergotamine, dihydroergotamine): Contraindicated. Concomitant use prolongs vasospastic reactions.
- Other 5-HT1 Agonists (Triptans): Contraindicated. Concomitant use within 24 hours may increase the risk of vasospastic reactions.
- MAO-B Inhibitors (e.g., selegiline, rasagiline): A theoretical risk exists, though the interaction is less pronounced than with MAO-A inhibitors. Caution is advised.
Missed dose
Imitrex is taken on an as-needed basis at the onset of a migraine attack. It is not taken on a scheduled daily regimen. Therefore, the concept of a “missed dose” does not apply. Do not take a dose to “make up” for a migraine that was not treated.
Overdose
Symptoms of overdose may be an exaggeration of the drug’s known pharmacological effects, including hypertension, cardiovascular events, seizures, and central nervous system depression. There is no specific antidote for sumatriptan overdose. Management consists of supportive care, including continuous ECG monitoring for at least 12-24 hours and symptomatic treatment. Hemodialysis is unlikely to be beneficial due to the large volume of distribution of sumatriptan. In case of suspected overdose, contact a Poison Control Center or seek immediate medical attention.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C (59°F to 86°F).
- Protect from light and moisture.
- Do not freeze the injection or nasal spray.
- Keep the autoinjector or nasal spray device in its protective case or carton until ready to use.
- Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- “As a neurologist with over 20 years of experience, I find Imitrex to be a cornerstone of acute migraine therapy. The subcutaneous formulation, in particular, offers unparalleled speed of onset for patients with rapidly escalating pain. Its efficacy in my patient population is consistently high when used appropriately and contraindications are respected.”
- “The availability of the nasal spray has been a game-changer for my patients who experience significant nausea at the onset of their migraines, making oral medications impractical. It provides a reliable and effective alternative route of administration.”
- “While highly effective, it is crucial to emphasize patient education on the associated sensations of pressure and tightness. Properly preparing patients for these common, typically benign, side effects prevents unnecessary emergency room visits for non-cardiac chest pain.”
- “The drug’s selectivity is its greatest strength, allowing for targeted relief of migraine symptoms. However, this same mechanism necessitates rigorous patient screening for cardiovascular risk factors prior to prescription. It remains a powerful tool when used judiciously within its approved indications.”